Efficacy and Safety of Ruxolitinib in Patients with Newly-Diagnosed Polycythemia Vera: Futility Analysis of the RuxoBEAT Clinical Trial of the GSG-MPN Study Group.

Steffen Koschmieder,Susanne Isfort,Dominik Wolf,Florian H. Heidel,Andreas Hochhaus,Philippe Schafhausen,Martin Griesshammer,Denise Wolleschak,Uwe Platzbecker,Konstanze Döhner,Philipp J. Jost,Stefani Parmentier,Markus Schaich,Nikolas von Bubnoff,Frank Stegelmann,Angela Maurer,Martina Crysandt,Deniz Gezer, Maike Kortmann,Jeremy Franklin,Julia Frank,Martin Hellmich,Tim H. Brümmendorf

ANNALS OF HEMATOLOGY（2023）

引用 3|浏览38
暂无评分
关键词
Polycythemia vera (PV),Randomized clinical trial,Efficacy and safety,Ruxolitinib,Best available therapy,German Study Group for myeloproliferative neoplasms (GSG-MPN)
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要